Litteratur om influensavaccinationer

Influensavaccinernas effektivitet

1. Belongia E. A., Simpson M. D., King J. P. ym.: Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies. Lancet Infect Dis 2016 16(8):942–51

2. Mertz D., Fadel S. A., Lam P-P., Tran D. ym.: Herd effect from influenza vaccination in nonhealthcare settings: a systematic review of randomized controlled trials and observational studies Euro Surveill. 2016 21(42) 20.10.2016

3. Osterholm M. T., Kelley N. S., Sommer A. ym.: Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012 12(1):36–44

4. Orenstein E. W., De Serres G., Haber M. J. ym.: Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness Int J Epidemiol 2007 36(3):623–631

Influensavaccination av hälsovårdspersonal 

1. De Serres G., Skowronski D. M., Ward B. J. ym.: Influenza Vaccination of Healthcare Workers: Critical Analysis of the Evidence for Patient Benefit Underpinning Policies of Enforcement PLOS ONE 27.1.2017

2. Hayward A. C., Fragaszy E. B., Bermingham A. ym.: Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study. Lancet Respir Med 2014 2(6):445–454.

3. Ahmed F., Lindley M. C., Allred N. ym.: Effect of influenza vaccination of healthcare personnel on morbidity and mortality among patients: systematic review and grading of evidence. Clin Infect Dis 2014 58(1):50–57.

4. Dolan G. P., Harris R. C., Clarkson M. ym.: Vaccination of health care workers to protect patients at increased risk for acute respiratory disease. Emerg Infect Dis 2012 18(8):1225–34.

5. Lemaitre M., Meret T., Rothan-Tondeur M. ym.: Effect of influenza vaccination of nursing home staff on mortality of residents: a cluster-randomized trial. J Am Geriatr Soc 2009 57(9):1580–6.

6. van den Dool C., Bonten M. J., Hak E., Wallinga J.: Modeling the effects of influenza vaccination of healthcare workers in hospital departments. Vaccine. 2009 27(44):6261–7.

7. Nichol K. L., Nordin J. D., Nelson D. B. ym.: Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med 2007 357:1373–81.

8. Hayward A. C., Harling R., Wetten S. ym.: Effectiveness of an influenza vaccine programme for care home staff to prevent death, morbidity, and health service use among residents: cluster randomised controlled trial. BMJ 2006 333:1241–7.

9. Burls A., Jordan R., Barton P., ym.: Vaccinating healthcare workers against influenza to protect the vulnerable—is it a good use of healthcare resources? A systematic review of the evidence and an economic evaluation. Vaccine 2006 24(19):4212–21.

10. Thomas R. E., Jefferson T. O., Demicheli D., Rivetti D.: Influenza vaccination for health-care workers who work with elderly people in institutions: a systematic review. Lancet Infect Dis 2006 6(5):273–9.

11. Carman W. F., Elder A. G., Wallace L. A. ym.: Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial. Lancet 2000 355(9198):93–7.

12. Potter J. M., O'Donnell B., Carman W. F. ym.: Serological response to influenza vaccination and nutritional and functional status of patients in geriatric medical long-term care. Age Aging 1999 28(2):141–145.

13. Wilde J. A., McMillan J. A., Serwint J. ym.: Effectiveness of influenza vaccine in health care professionals: a randomized trial. JAMA 1999 281(10):908–13.

14. Saxen H, Virtanen M. Randomized placebo-controlled double blind study on the efficacy of influenza immunization on absenteeism of health care workers. Pediatr Infect Dis J 1999 18(9):779–83.

15. Potter J., Stott D. J., Roberts M. A. ym.: Influenza vaccination of health care workers in long-term-care hospitals reduces the mortality of elderly patients. J Infect Dis 1997 175(1):1–6.

16. Govaert T. M., Thijs C. T., Masurel N. ym.: The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA 1994 272(21):1661–5.

17. Gross P. A., Quinnan G. V. Jr., Weksler M. E. ym.: Relation of chronic disease and immune response to influenza vaccine in the elderly. Vaccine 1989 7(4):303–308.

18. Stowe J., Andrews N., Wise L., Miller E.: Investigation of the temporal association of Guillain-Barré syndrome with influenza vaccine and influenza like illness using the United Kingdom General Practice Research Database. Am J Epidemiol 2009 169(3):382–388.

Influensavaccinernas säkerhet

1. Juurlink D. N., Stukel T. A., Kwong J. ym.: Guillain-Barré Syndrome After Influenza Vaccination in Adults: A Population-Based Study. Arch Intern Med 2006 166(20):2217–2221.

2. Kwong J. C., Vasa PP, Campitelli MA ym.: Risk of Guillain-Barré syndrome after seasonal influenza vaccination and influenza health-care encounters: a self-controlled study. Lancet Infect Dis 2013 13(9):769–76

Samtidigt administrering av influensa- och coronavaccinationer

Lazarus R., Baos S., Cappel-Porter H. ym.: Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial. The Lancet 2021 398(10318):2277-87

Nässprayvaccinationer för barn med astma

1. Turner P. J., Fleming L., Saglani S. ym.: Safety of live attenuated influenza vaccine (LAIV) in children with moderate to severe asthma. Journal of Allergy and Clinical Immunology 2020 145(4):1157-64

2. Sokolow A. G., Stallings A. P., Kercsmar C. ym.: Safety of Live Attenuated Influenza Vaccine in Children With Asthma. Pediatrics 28.3.2022